Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Horizon Therapeutics Public Limited Company (HZNP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
115.690.00 (0.00%)
At close: 04:00PM EDT
115.68 -0.01 (-0.01%)
After hours: 07:22PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/30/2023
Current
6/30/20233/31/202312/31/20229/30/2022
Market Cap (intraday)
26.49B23.55B24.95B25.83B14.15B
Enterprise Value
26.55B23.77B25.14B26.24B14.83B
Trailing P/E
61.5465.0949.1646.8319.10
Forward P/E
20.9619.0121.2821.8812.39
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
7.436.757.077.263.84
Price/Book (mrq)
4.994.624.925.142.86
Enterprise Value/Revenue
7.2925.1530.2227.8516.02
Enterprise Value/EBITDA
29.4597.55194.0196.5857.78

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 380.03%
S&P500 52-Week Change 316.57%
52 Week High 3115.87
52 Week Low 360.03
50-Day Moving Average 3108.54
200-Day Moving Average 3108.17

Share Statistics

Avg Vol (3 month) 32.27M
Avg Vol (10 day) 31.58M
Shares Outstanding 5229M
Implied Shares Outstanding 6229M
Float 8211.18M
% Held by Insiders 11.18%
% Held by Institutions 1100.85%
Shares Short (Sep 14, 2023) 47.1M
Short Ratio (Sep 14, 2023) 42.04
Short % of Float (Sep 14, 2023) 43.12%
Short % of Shares Outstanding (Sep 14, 2023) 43.10%
Shares Short (prior month Aug 14, 2023) 47.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023

Profitability

Profit Margin 12.02%
Operating Margin (ttm)17.68%

Management Effectiveness

Return on Assets (ttm)4.44%
Return on Equity (ttm)8.54%

Income Statement

Revenue (ttm)3.64B
Revenue Per Share (ttm)15.94
Quarterly Revenue Growth (yoy)7.80%
Gross Profit (ttm)2.8B
EBITDA 669.21M
Net Income Avi to Common (ttm)438M
Diluted EPS (ttm)1.87
Quarterly Earnings Growth (yoy)108.40%

Balance Sheet

Total Cash (mrq)2.48B
Total Cash Per Share (mrq)10.85
Total Debt (mrq)2.73B
Total Debt/Equity (mrq)51.32%
Current Ratio (mrq)4.27
Book Value Per Share (mrq)23.20

Cash Flow Statement

Operating Cash Flow (ttm)1.04B
Levered Free Cash Flow (ttm)824.71M
Advertisement
Advertisement